Protective effect of the oral administration of cystine and theanine on oxaliplatin-induced peripheral neuropathy: a pilot randomized trial
ConclusionThe results demonstrated the daily oral administration of cystine and theanine attenuated OXLIPN.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Colorectal Cancer | Eloxatin | Neurology | Oral Cancer | Peripheral Neuropathy | Study